Analysis of TCGA datasets further confirmed that TRMT112 is considerably overexpressed across multiple malignancies, including breast, bladder, colon, esophageal, head and neck, renal clear cell, hepatocellular, and lung squamous cell carcinomas. The gene discussed is TRMT112; the disease is squamous cell lung carcinoma.